Rare diseases
Investigational molecules
Locations
Back to Romania11 clinical trials in Braila, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
RomaniaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
RomaniaStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
RomaniaEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
RomaniaA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
RomaniaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
RomaniaStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
RomaniaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
RomaniaBaricitinib Compared with Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
RomaniaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
RomaniaStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on atherosclerotic cardiovascular disease prevention through advanced therapeutic approaches. Studies are evaluating new treatments to reduce the risk of major cardiovascular events.
Clinical investigations aim to demonstrate the effectiveness of novel medications in preventing adverse cardiovascular outcomes in high-risk patients.
Comprehensive studies examining new therapeutic options for patients with atrial fibrillation, particularly focusing on stroke prevention and systemic embolism reduction.
Research targets both standard anticoagulation approaches and solutions for patients unsuitable for conventional treatments.
Groundbreaking research exploring combination therapies for heart failure patients, investigating new treatment approaches to improve patient outcomes.
Studies focus on evaluating innovative therapeutic combinations to enhance heart failure management and reduce hospitalizations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
